Labels of all iodinated contrast media (ICM) products will include information about these cases. No changes to current prescribing, administration, or monitoring practices are recommended. MedWatch Safety Alert RSS Feed
Content is copyrighted by the respective owners.
Advertisement: Looking for a rental home or apartment? www.PutnamRentals.info
Buying or selling real estate in Putnam NY? […]
Title: Minorities, Poor More Likely to Be Diagnosed With Advanced Thyroid CancerCategory: Health NewsCreated: 1/13/2014 12:35:00 PMLast Editorial Review: 1/14/2014 12:00:00 AM MedicineNet Daily News
UCLA researchers have found that minority patients and those of lower socioeconomic status are far more likely to have advanced thyroid cancer when they are diagnosed with the disease than white patients and those in higher economic brackets.
In one of the most comprehensive studies of its kind, the UCLA team looked at […]
Nature Reviews Endocrinology 10, 2 (2014). doi:10.1038/nrendo.2013.224
Author: Claire Greenhill
A new study has found that most patients with active Graves ophthalmopathy respond to a 6–8 week course of intravenous glucocorticoids. These findings call into question whether the standard 12-week course is necessary in patients who do not respond by 8 weeks.Glucocorticoids are the […]
Neither clinical nor subclinical hypothyroidism was associated with mild cognitive impairment in a large, population-based study.
Among almost 2,000 elderly subjects, mild cognitive impairment (MCI)…
Internal Medicine News